BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹40 Cr | ₹45 Cr | ₹41 Cr | ₹15 Cr | ₹9.56 Cr |
What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹9.56 Cr |
How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | -11.50 | |
| Mar2024 | ₹45 Cr | 10.32 | |
| Mar2023 | ₹41 Cr | 178.41 | |
| Mar2022 | ₹15 Cr | 54.60 | |
| Mar2021 | ₹9.56 Cr | - | |
Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹321.6 Cr | -2.5% | 22.5% | 73.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -2.5% |
22.5% |
73.5% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses